BLOG

The 3Rs philosophy is the guiding principle for the Animal Welfare Program at Altasciences.

2020 has been quite a year! Each year, we strive to provide you with a more innovative, simplified, and seamless early phase drug development journey. And the past 12 months have been no exception.

Meet Altasciences' Dr. Lynne Le Sauteur, PhD, Vice President of Laboratory Sciences.

Hallucinogens, dissociatives and other Schedule I drugs are increasingly being found to have a clinical application in a number of therapeutic areas. Recent approvals, background, and related case studies in this month's blog.

The formulation of an active pharmaceutical ingredient (API) to ensure maximum bioavailability is central to successful drug development. When an API is insoluble or poorly soluble, it will require processing...

Choose a clinical research partner with expertise in site management.